Sinar Eka Selaras Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Sinar Eka Selaras Tbk. trades at Rp300 (market cap 1.57T, 1.22M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp264 (market cap 470.58B, 18.86M 24h volume). The key difference: Sinar Eka Selaras Tbk. is far larger — about 3.3× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (18.86M versus 1.22M). Which is the better fit depends on your goals.
| ERAL | PRDL | |
|---|---|---|
Market Cap | 1.57T | 470.58B |
Volume | 1.22M | 18.86M |
Lot | 12.23K | 188.57K |
Turnover | 366.6M | 4.97B |
Average Price | 299.85 | 263.63 |
Value | 366.6M | 4.97B |
Indicative Equilibrium Price | 300 | 264 |
Indicative Equilibrium Volume | 73 | 3.64K |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinar Eka Selaras Tbk (the “Company”) was established in Indonesia based on Notarial Deed No. 12 of Myra Yuwono, S.H., dated March 13, 2009. PT Erajaya Swasembada Tbk, an entity incorporated in Indonesia, is the parent company of the Company. PT Eralink International, an entity incorporated inIndonesia, is the ultimate parent of the Company.
Read more on ERAL →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →